Variants in the 3′UTR of SNCA do not affect miRNA-433 binding and alpha-synuclein expression

European Journal of Human Genetics

Volumn 20, Issue 12, 2012, Pages 1265-1269

  Schmitt, Ina ^a,b   Wüllner, Ullrich ^a,b   Van Rooyen, Jan Pierre ^c   Khazneh, Hassan ^a   Becker, Julian ^a   Volk, Alexander ^c,d   Kubisch, Christian ^c,d   Becker, Tim ^a   Kostic, Vladimir S ^e   Klein, Christine ^f   Ramirez, Alfredo ^a,c  

^a UNIVERSITY OF BONN   (Germany)

^b GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^c UNIVERSITY OF COLOGNE   (Germany)

^d UNIVERSITY OF ULM   (Germany)

^e UNIVERSITY OF BELGRADE   (Serbia)

^f UNIVERSITY OF LÜBECK   (Germany)

Author keywords

30UTR; expression; miRNA 433; Parkinson's disease; SNCA

Indexed keywords

ALPHA SYNUCLEIN; MESSENGER RNA; MICRORNA; MICRORNA 433; UNCLASSIFIED DRUG; MIRN433 MICRORNA, HUMAN; SNCA PROTEIN, HUMAN;

3' UNTRANSLATED REGION; ADULT; AGED; ARTICLE; CODON; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE MUTATION; GENE STRUCTURE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA STABILITY; SINGLE NUCLEOTIDE POLYMORPHISM; ALLELE; CASE CONTROL STUDY; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; MIDDLE AGED;

PARKINSONIA;

3' UNTRANSLATED REGIONS; ADULT; AGED; ALLELES; ALPHA-SYNUCLEIN; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MICRORNAS; MIDDLE AGED; PARKINSON DISEASE; POLYMORPHISM, SINGLE NUCLEOTIDE; TRANSCRIPTION, GENETIC;

EID: 84869228626     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2012.84     Document Type: Article

References (20)

1. Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M: Alphasynuclein in Lewy bodies. Nature 1997; 388: 839-840.
2. Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E: Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003; 24: 197-211. (Pubitemid 36007810)
3. Singleton AB, Farrer M, Johnson J et al: Alpha-Synuclein locus triplication causes Parkinson's disease. Science 2003; 302: 841. (Pubitemid 37339619)
4. Mizuta I, Satake W, Nakabayashi Y et al: Multiple candidate gene analysis identifies alpha-synuclein as a susceptibility gene for sporadic Parkinson's disease. Hum Mol Genet 2006; 15: 1151-1158.
5. Satake W, Nakabayashi Y, Mizuta I et al: Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease. Nat Genet 2009; 41: 1303-1307.
6. Simon-Sanchez J, Schulte C, Bras JM et al: Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat Genet 2009; 41: 1308-1312.
7. Fuchs J, Tichopad A, Golub Y et al: Genetic variability in the SNCA gene influences alpha-synuclein levels in the blood and brain. The FASEB J 2008; 22: 1327-1334. (Pubitemid 351656774)
8. Doxakis E: Post-transcriptional regulation of alpha-synuclein expression by mir-7 and mir-153. J Biol Chem 2010; 285: 12726-12734.
9. Junn E, Lee KW, Jeong BS, Chan TW, Im JY, Mouradian MM: Repression of alphasynuclein expression and toxicity by microRNA-7. Proc Natl Acad Sci USA 2009; 106: 13052-13057.
10. Daniel SE, Lees AJ: Parkinson's Disease Society Brain Bank, London: overview and research. J Neural Transm Suppl, 1993; 39: 165-172. (Pubitemid 23216938)
11. Armitage P: Tests for linear trends in proportions and frequencies. Biometrics 1955; 11: 375-386.
12. Herold C, Steffens M, Brockschmidt FF, Baur MP, Becker T: INTERSNP: genomewide interaction analysis guided by a priori information. Bioinformatics 2009; 25: 3275-3281.
13. Chung BD, Kayserili H, Ai M et al: A mutation in the signal sequence of LRP5 in a family with an osteoporosis-pseudoglioma syndrome (OPPG)-like phenotype indicates a novel disease mechanism for trinucleotide repeats. Hum Mutat 2009; 30: 641-648.
14. Xu Q, Wang Y, Dabdoub A et al: Vascular development in the retina and inner ear: control by Norrin and Frizzled-4, a high-affinity ligand-receptor pair. Cell 2004; 116: 883-895. (Pubitemid 38410732)
15. Cardo LF, Coto E, de Mena L et al: A search for SNCA 3' UTR variants identified SNP rs356165 as a determinant of disease risk and onset age in Parkinson's disease. J Mol Neurosci 2011; e-pub ahead of print 11 November 2011; doi:10.1007/s12031-011-9669-1.
16. Wang G, van der Walt JM, Mayhew G et al: Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of alpha-synuclein. Am J Hum Genet 2008; 82: 283-289.
17. Grundemann J, Schlaudraff F, Haeckel O, Liss B: Elevated alpha-synuclein mRNA levels in individual UV-laser-microdissected dopaminergic substantia nigra neurons in idiopathic Parkinson's disease. Nucleic Acids Res 2008; 36: e38.
18. Winkler S, Hagenah J, Lincoln S et al: Alpha-Synuclein and Parkinson disease susceptibility. Neurology 2007; 69: 1745-1750.
19. International Parkinson's Disease Genomics Consortium (IPDGC); Wellcome Trust Case Control Consortium 2(WTCCC2): A two-stage meta-analysis identifies several new loci for Parkinson's disease. PLoS Genet 2011; 7: e1002142.
20. Spencer CC, Plagnol V, Strange A et al: Dissection of the genetics of Parkinson's disease identifies an additional association 5' of SNCA and multiple associated haplotypes at 17q21. Hum Mol Genet 2011; 20: 345-353.